Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
You might think that an intense burst of exercise would only make you more ravenous and reaching for piles of hot buttered ...
A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...
The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...
When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...
For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...
Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...
If you’ve been using a GLP-1 such as semaglutide, then you’ve likely experienced the powerful effects of this weight loss ...
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...
Dr. Sue Mitchell is an experienced gastroenterologist with a background in functional medicine, internal medicine and ...